Free Trial

Solid Biosciences (SLDB) Earnings Date, Estimates & Call Transcripts

Solid Biosciences logo
$4.41 -0.05 (-1.12%)
(As of 12:51 PM ET)

Solid Biosciences Latest Earnings Summary

Actual EPS
(Nov. 6)
-$0.79 Missed By -$0.12
Consensus EPS
(Nov. 6)
-$0.67

Solid Biosciences posted Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.79, which missed analysts' consensus estimates of -$0.67 by $0.12. With a trailing EPS of -$3.04, Solid Biosciences' earnings are expected to grow next year, from ($2.85) to ($2.79) per share.

Get Solid Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Solid Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SLDB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SLDB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Solid Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.98-$0.98-$0.98
Q2 20242-$0.72-$0.69-$0.71
Q3 20243-$0.70-$0.67-$0.69
Q4 20243-$0.85-$0.68-$0.78
FY 20249-$3.25-$3.02-$3.15
Q1 20253-$0.86-$0.74-$0.80
Q2 20253-$0.87-$0.77-$0.81
Q3 20253-$0.88-$0.75-$0.81
Q4 20253-$0.88-$0.77-$0.81
FY 202512($3.49)($3.03)($3.24)

Solid Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024--$0.67-$0.79 -$0.12-$0.79--
8/13/2024Q2 2024-$0.66-$0.61+$0.05-$0.61--
5/15/2024Q1 2024-$0.57-$0.64 -$0.07-$0.64--
3/13/2024Q4 2023-$1.01-$1.00+$0.01-$1.00--
11/8/2023Q3 2023-$1.20-$1.05+$0.15-$1.05--
8/14/2023Q2 2023-$1.52-$1.25+$0.27-$1.25--
5/11/2023Q1 2023-$1.83-$1.54+$0.29-$1.54--
3/23/2023Q4 2022-$2.70-$0.68+$2.02-$0.68--

Solid Biosciences Earnings - Frequently Asked Questions

Solid Biosciences (NASDAQ:SLDB) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on SLDB's earnings history.

In the previous quarter, Solid Biosciences (NASDAQ:SLDB) missed the analysts' consensus estimate of ($0.67) by $0.12 with a reported earnings per share (EPS) of ($0.79). Learn more on analysts' earnings estimate vs. SLDB's actual earnings.

Solid Biosciences (NASDAQ:SLDB) has a recorded annual revenue of $8.09 million.

Solid Biosciences (NASDAQ:SLDB) has a recorded net income of -$96.01 million. SLDB has generated -$3.04 earnings per share over the last four quarters.

Solid Biosciences's earnings are expected to grow from ($2.85) per share to ($2.79) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:SLDB) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners